applicability of the procedure was evaluated with separated soluble fractions of the two beta-galactosidases from normal human brains , and with whole homogenates of gray and white matter , liver and cultured fibroblasts from control individuals and from patients with globoid cell leukodystrophy or gm1-gangliosidosis .
C0184661
procedure
C0220825
evaluated